You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Onivyde

Showing 1 - 25 of 46
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Metastatic Gastric Adenocarcinoma, Second Line, Chemo Trial (nal-IRI /Experimental, Ramucirumab /Experimental,

Not yet recruiting
  • Metastatic Gastric Adenocarcinoma
  • +2 more
  • nal-IRI /Experimental
  • +2 more
  • (no location specified)
Jun 25, 2023

Metastatic Pancreatic Adenocarcinoma Trial in Worldwide (Irinotecan liposome injection, Folinic Acid, 5-Fluorouracil)

Recruiting
  • Metastatic Pancreatic Adenocarcinoma
  • Irinotecan liposome injection
  • +2 more
  • Bedford Park, Australia
  • +35 more
Jan 24, 2023

Metastatic Biliary Tract Cancer Trial in Seoul (Onivyde, 5-FU/LV)

Completed
  • Metastatic Biliary Tract Cancer
  • Seoul, Korea, Republic of
    Asan Medical Center
Aug 22, 2022

Tolerability of Liposomal Irinotecan

Active, not recruiting
  • Metastatic Pancreatic Ductal Adenocarcinoma
  • Onivyde® + 5-FULV
  • Edegem, Belgium
    Antwerp University Hosptital
Jan 31, 2022

GEP-NET Trial in Taiwan (nanoliposomal irinotecan plus carboplatin)

Not yet recruiting
  • GEP-NET
  • nanoliposomal irinotecan plus carboplatin
  • Kaohsiung, Taiwan
  • +5 more
May 17, 2022

Recurrent Solid Tumor, Recurrent Ewing Sarcoma, Recurrent Hepatoblastoma Trial in Canada, United States (Onivyde, Talazoparib,

Recruiting
  • Recurrent Solid Tumor
  • +21 more
  • Onivyde
  • +2 more
  • Palo Alto, California
  • +8 more
Jun 7, 2022

Peritoneal Carcinomatosis, Peritoneal Metastases, Colorectal Cancer Trial in Ghent (PIPAC with Nal-IRI)

Recruiting
  • Peritoneal Carcinomatosis
  • +7 more
  • PIPAC with Nal-IRI
  • Ghent, East-Flanders, Belgium
    UZ Ghent
Dec 28, 2022

Post Marketing Surveillance Study for ONIVYDE® in South Korea

Completed
  • Metastatic Pancreatic Cancer
  • ONIVYDE
  • +2 more
  • Daejeon, Korea, Republic of
  • +9 more
Sep 27, 2021

Refractory Solid Tumors Trial in Taichung, Tainan (Nanoliposomal Irinotecan)

Active, not recruiting
  • Refractory Solid Tumors
  • Nanoliposomal Irinotecan
  • Taichung, Taiwan
  • +1 more
Sep 16, 2021

Pancreatic Cancer Trial in New Orleans, Dallas (XB2001 or Placebo)

Recruiting
  • Pancreatic Cancer
  • XB2001 or Placebo
  • Tucson, Arizona
  • +27 more
Jan 27, 2023

Rhabdomyosarcoma Trial in Palo Alto, Memphis, Fort Worth (Vincristine, Dactinomycin, Cyclophosphamide)

Not yet recruiting
  • Rhabdomyosarcoma
  • Palo Alto, California
  • +2 more
Aug 27, 2023

Small-cell Lung Cancer, Small Cell Lung Carcinoma Trial in Saint Louis (Mycophenolate Mofetil, Allopurinol, Irinotecan)

Not yet recruiting
  • Small-cell Lung Cancer
  • Small Cell Lung Carcinoma
  • Mycophenolate Mofetil
  • +2 more
  • Saint Louis, Missouri
    Washington University School of Medicine
May 17, 2022

Childhood CNS Tumor Trial in Washington (genetic, radiation, drug)

Not yet recruiting
  • Childhood CNS Tumor
  • SGT-53
  • +4 more
  • Washington, District of Columbia
    Children's National Medical Center
Feb 7, 2022

Pancreatic Ductal Adenocarcinoma Trial in United States (Onvansertib, Nanoliposomal irinotecan, Leucovorin)

Recruiting
  • Pancreatic Ductal Adenocarcinoma
  • Phoenix, Arizona
  • +5 more
Dec 15, 2022

Pancreatic Cancer, Unresectable Pancreatic Cancer, Metastatic Pancreatic Cancer Trial (Sotorasib, Liposomal Irinotecan

Not yet recruiting
  • Pancreatic Cancer
  • +3 more
  • (no location specified)
Feb 11, 2022

Pancreatic Cancer, Cachexia, Weight Loss Trial in Los Angeles (Xilonix plus Onivyde and 5FU)

Completed
  • Pancreatic Cancer
  • +2 more
  • Xilonix plus Onivyde and 5FU
  • Los Angeles, California
    Cedars-Sinai Medical Center
Dec 29, 2020

Oncology, Neuroendocrine Carcinoma Trial in United Kingdom (Liposomal Irinotecan, Fluorouracil, Folinic Acid)

Active, not recruiting
  • Oncology
  • Neuroendocrine Carcinoma
  • Liposomal Irinotecan
  • +3 more
  • Glasgow, United Kingdom
  • +3 more
Dec 2, 2022

Colorectal Adenocarcinoma, Gastric Adenocarcinoma, Metastatic Pancreatic Adenocarcinoma Trial in Atlanta (Nanoliposomal

Recruiting
  • Colorectal Adenocarcinoma
  • +13 more
  • Nanoliposomal Irinotecan
  • Trifluridine and Tipiracil Hydrochloride
  • Atlanta, Georgia
  • +2 more
Jan 6, 2023

Malignant Tumor of Pancreas Metastatic to Liver Trial (Anti-CEA CAR-T cells, gemcitabine/nab paclitaxel, NLIR+FU/FA)

Withdrawn
  • Malignant Tumor of Pancreas Metastatic to Liver
  • Anti-CEA CAR-T cells
  • +3 more
  • (no location specified)
Mar 30, 2022

Biliary Tract Cancer Trial in United States (Nivolumab, Nanoliposomal-Irinotecan, 5-Fluorouracil)

Active, not recruiting
  • Biliary Tract Cancer
  • Ann Arbor, Michigan
  • +4 more
Oct 6, 2022

Malignant Solid Tumor Trial in United States (drug, other, procedure)

Active, not recruiting
  • Malignant Solid Neoplasm
  • Baltimore, Maryland
  • +5 more
Nov 8, 2022

Pancreatic Adenocarcinoma Trial in Verona (Irinotecan Liposomal Injection [Onivyde]; oxaliplatin, 5-FU; Levofolinic Acid)

Recruiting
  • Pancreatic Adenocarcinoma
  • Irinotecan Liposomal Injection [Onivyde]; oxaliplatin, 5-FU; Levofolinic Acid
  • Verona, Italy
    Centro Ricerche Cliniche
Jul 27, 2021

Pancreatic Cancer Trial in Seongnam-si, Seoul (Irinotecan Liposomal Injection [Onivyde], Capecitabine, 5-fluorouracil)

Recruiting
  • Pancreatic Cancer
  • Irinotecan Liposomal Injection [Onivyde]
  • +3 more
  • Seongnam-si, Korea, Republic of
  • +1 more
Sep 22, 2021

Pancreatic Cancer, Pancreas Cancer, Cancer of the Pancreas Trial in Saint Louis (5-FU, Leucovorin, Liposomal Irinotecan)

Active, not recruiting
  • Pancreatic Cancer
  • +2 more
  • Saint Louis, Missouri
    Washington University School of Medicine
Sep 29, 2021

Squamous Cell Carcinoma Trial in France (Onivyde, Paclitaxel)

Recruiting
  • Squamous Cell Carcinoma
  • Amiens, France
  • +8 more
Dec 6, 2021